Cymbiotika Secures Fifth Consecutive Spot on Inc. 5000

Since its founding in 2019, the company has transitioned from a digitally native startup into a prominent wellness supplier. This growth is anchored in a strategy that balances a robust direct-to-consumer model with an expanding retail footprint, including recent product placements at Target, Ulta Beauty, and Whole Foods Market. CEO and co-founder Shahab Elmi attributed the milestone to the team's ongoing commitment to product quality and consumer accessibility.

The Inc. 5000 ranking evaluates companies based on percentage revenue growth over a three-year period. To qualify for the 2026 edition, businesses were required to meet specific financial thresholds, including a minimum revenue of $100,000 in 2022 and $2 million by the end of 2025. By maintaining this pace of development, Cymbiotika remains among the select group of independent firms recognized by the publication for their resilience and operational scaling.